Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 9/2012

01-09-2012 | Editorial

Biosimilars in rheumatology: a view from Latin America

Authors: Eduardo Mysler, Morton Scheinberg

Published in: Clinical Rheumatology | Issue 9/2012

Login to get access

Excerpt

The treatment of inflammatory arthritis has been revolutionized in the past decade by the introduction of targeted biologic therapies. They are genetically engineered monoclonal or fusion proteins that could interfere with the biological activity of cytokines or inhibit T cell co-stimulation or could deplete B cell [1]. …
Literature
1.
Pisetsky DS, Ward MM (2012) Advances in the treatment of inflammatory arthritis. Best Pract Res Clin Rheumatol 26:251–261PubMedCrossRef
2.
Mellstedt H, Niederwieser D, Ludwig H (2008) The challenge of biosimilars. Ann Oncol 19(3):411–419, Epub 2007 Sep 14. ReviewPubMedCrossRef
3.
Knezevic I, Griffiths E (2011) Biosimilars—global issues, national solutions. Biologicals 39(5):252–255, Epub 2011 Sep 15. ReviewPubMedCrossRef
4.
5.
6.
Kozlowski S, Woodcock J, Midthun K, Sherman RB (2011) Developing the nation’s biosimilars program. N Engl J Med 365(5):385–388PubMedCrossRef
7.
Scheinberg MA, Kay J (2012) The advent of biosimilar therapies in rheumatology—“O Brave New World”. Nat Rev Rheumatol 8:430–436PubMedCrossRef
8.
9.
COMITÉ DE PRODUCTOS BIOLÓGICOS ANAMED (2001) PROPUESTA DE NORMA Y ASPECTOS TÉCNICOS PARA LA EVALUACIÓN DE PRODUCTOS FARMACÉUTICOS BIOTECNOLÓGICOS DERIVADOS DE TÉCNICAS ADN RECOMBINANTES. Versión 8.2 Fecha: 12-10-11
Metadata
Title
Biosimilars in rheumatology: a view from Latin America
Authors
Eduardo Mysler
Morton Scheinberg
Publication date
01-09-2012
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 9/2012
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-012-2068-3

Other articles of this Issue 9/2012

Clinical Rheumatology 9/2012 Go to the issue

Original Article

Correlations between histopathologic and scintigraphic parameters of salivary glands in patients with Sjögren’s syndrome

Original Article

Effect of 12 months treatment with chondroitin sulfate on cartilage volume in knee osteoarthritis patients: a randomized, double-blind, placebo-controlled pilot study using MRI

Original Article

Do hip OA patients referred to orthopedic surgeons by general practitioners and rheumatologists differ?

Letter to the Editor

Giant cell arteritis with normal C-reactive protein and risk of ocular complications

Case Based Review

Improvement in insulin resistance after short-term treatment with abatacept: case report and short review

Original Article

Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjögren’s syndrome
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits